A PROSPECTIVE OBSERVATIONAL STUDY ON EFFECTS OF HEPATOPROTECTIVE AGENTS IN ALCOHOLIC LIVER DISEASE AT A TERTIARY CARE HOSPITAL
暂无分享,去创建一个
[1] L. Vale,et al. The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial. , 2015, Health technology assessment.
[2] L. Leggio,et al. Pharmacotherapy for alcoholic patients with alcoholic liver disease. , 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[3] J. Fenkel,et al. Treatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline. , 2013, JAMA.
[4] T. Roskams,et al. EASL clinical practical guidelines: management of alcoholic liver disease. , 2012, Journal of hepatology.
[5] M. Kotb. Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode , 2012, International journal of molecular sciences.
[6] M. Roma,et al. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. , 2011, Clinical science.
[7] P. Deltenre,et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. , 2009, Gastroenterology.
[8] J. Reichen. Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis. , 2008, ACP journal club.
[9] K. Hübner,et al. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up , 1985, Digestive Diseases and Sciences.
[10] A. Hofmann,et al. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis part II , 1982, Digestive Diseases and Sciences.
[11] F. Gudé,et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. , 2004, Alcoholism, clinical and experimental research.
[12] B. Borisch,et al. Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood. , 2001, Journal of hepatology.
[13] K. Ikejima,et al. Sex difference in alcohol-related organ injury. , 2001, Alcoholism, clinical and experimental research.
[14] T. Reynolds,et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[15] L. Midanik,et al. The effect of screening on prevalence estimates of alcohol dependence and social consequences. , 2000, Journal of studies on alcohol.
[16] P. Cluzel,et al. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. , 2000, Journal of hepatology.
[17] B. Balkau,et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression , 1999, Hepatology.
[18] H Wechsler,et al. Binge drinking: the five/four measure. , 1998, Journal of studies on alcohol.
[19] M. R. Jackson,et al. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia. , 1997, The Annals of thoracic surgery.
[20] T. Sørensen,et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study , 1996, Hepatology.
[21] U. Steinbrecher,et al. The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.
[22] A. Hofmann,et al. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. , 1993, Journal of lipid research.
[23] E. Christensen,et al. Ursodeoxycholic Acid for Primary Biliary Cirrhosis? , 1987, The Cochrane database of systematic reviews.
[24] M. Morgan. Hepatoprotective agents in alcoholic liver disease. , 2009, Acta medica Scandinavica. Supplementum.
[25] R. Murray,et al. COMPARISON OF QUESTIONNAIRE AND LABORATORY TESTS IN THE DETECTION OF EXCESSIVE DRINKING AND ALCOHOLISM , 1982, The Lancet.